BioStable Science & Engineering
Austin, US · Delaware corporation · 1 known investors
Cardiovascular device company developing HAART aortic valve repair technologies as an alternative to valve replacement. Assets acquired by Corcym in 2023.
Founders & leadership
JW
John WheelerExecutive Officer, Director
JC
Joe CunninghamDirector
DA
David AdairDirector
DS
David StrongDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$4.2MraisedMar 2020 · 9 investors · Other TechnologyRule 506(b)
▶$4.2MraisedMar 2020 · 9 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- John WheelerExecutive Officer, Director
- Joe CunninghamDirector
- David AdairDirector
- David StrongDirector
- Offering amount
- $4.2M
- Amount sold
- $4.2M
- First sale
- Feb 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.